Forrester Pharma

Forrester Pharma is a South African pharmaceutical company specializing in the marketing and distribution of generic prescription medicines. Founded in 2010, the company focuses on high-growth therapeutic areas such as oncology, cardiovascular health, and anti-infectives. It was acquired by Ascendis Health in 2017 to strengthen its pharmaceutical division and later became part of the Ascendis Pharma business unit. In 2022, this division was sold to a consortium comprising Pharma-Q and Imperial Logistics. Forrester Pharma provides a wide range of affordable, high-quality pharmaceutical products to both the private and public healthcare sectors in South Africa.